Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.12.2003 | Invited Commentary

Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

verfasst von: M. Gnant

Erschienen in: European Surgery | Ausgabe 6/2003

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

Nächster Artikel Solitary Cecal Diverticulitis: Report of a Case

Titel: Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma
verfasst von: M. Gnant
Publikationsdatum: 01.12.2003
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 6/2003
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-003-0045-4

Weitere Artikel der Ausgabe 6/2003

Splenic Abscess and Infarction – Rare Events for Which Surgery Is Mandatory

Original Scientific Paper

Solitary Cecal Diverticulitis: Report of a Case

Invited Commentary

Surgical Interventions for Renal Replacement Therapy from the View of Nephrologists

Main Topic

Splenic Abscess and Infarction – Rare Events for Which Surgery Is Mandatory

Invited Commentary

Continuous Ambulatory Peritoneal Dialysis – Surgical Technique, Early and Late Complications

Main Topic

Splenic Abscess and Infarction – Rare Events for Which Surgery Is Mandatory

Invited Commentary